Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot Study
BREHAB
1 other identifier
interventional
40
1 country
1
Brief Summary
Prehabilitation and rehabilitation through personalized lifestyle counseling in patients with breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Dec 2022
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 6, 2022
CompletedFirst Posted
Study publicly available on registry
October 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedMay 16, 2024
May 1, 2024
1 year
December 6, 2022
May 14, 2024
Conditions
Outcome Measures
Primary Outcomes (6)
Recruitment/consent rate
To estimate patient recruitment/consent rate to the prehabilitation/rehabilitation group Enrolment logs will be recorded for all patients who meet the eligibility criteria. Reasons for non-participation will be recorded. We define a success criterion of 40% of the total number of participants invited to be recruited to the pilot study.
From baseline to 6 months postoperatively
Attendance rate
To estimate patient attendance, measured by the number of sessions attended out of 10. Reasons for non-attendance will be collected and withdrawals tracked. We will consider an attendance rate of 80% satisfactory
From baseline to 6 months postoperatively
Patient adherence
To estimate patient adherence monitored with the aid of the wearables. Adherence is defined as at least 150 min of moderate intensity exercise and at least two strength training sessions per week. Exercise instructions are based on the Health Council's exercise guidelines. We will consider an adherence of 70% as satisfactory.
From baseline to 6 months postoperatively
Withdrawals
To estimate the number of withdrawals, defined as the proportion of patients who quit the intervention before reaching the primary endpoint (HRQOL at six months after surgery). Information about the reasons for withdrawal will be collected.
From baseline to 6 months postoperatively
Patient satisfaction
To estimate patient satisfaction with the programme assessed during three interviews: at four weeks, at three months after surgery and at the end of the study. Satisfaction is defined as: satisfaction with the lifestyle coach, satisfaction with the duration of the intervention, satisfaction with the physical training programme. Patients will be given room for their own input to improve the intervention.
From baseline to 6 months postoperatively
Selection bias
To explore any evidence of selection bias in participants recruited into the study (assessed through participant characteristics at baseline).
From baseline to 6 months postoperatively
Secondary Outcomes (10)
Likely changes in Health Related Quality of Life (HRQOL)
Baseline, the day before surgery, 6 months postoperatively
Likely changes in BMI
Baseline, the day before surgery, 6 months postoperatively
Likely changes in functional capacity (physical fitness)
Baseline, the day before surgery, 6 months postoperatively
Likely changes in the number of postoperative complications
30 days after surgery
Likely changes in smoking status
Measured at baseline and 6 months postoperatively
- +5 more secondary outcomes
Study Arms (2)
Prehabilitation/rehabilitation
EXPERIMENTALPatients in this arm follow a lifestyle counseling programme starting from diagnosis up to 6 months postoperatively.
Usual care
NO INTERVENTIONPatients in this arm follow usual care.
Interventions
A personalized lifestyle counseling programme.
Eligibility Criteria
You may qualify if:
- Woman with a confirmed breast cancer diagnosis
- Planned surgical treatment of breast cancer
- Age 18 years or older
- Provision of written informed consent
You may not qualify if:
- Severe mental retardation, which limits the ability to follow instructions independently
- Severe psychiatric problems, which limits the ability to follow instructions independently
- Legal incapacity
- Language barrier: If we cannot find a lifestyle coach who speaks the patient's language, unfortunately we cannot offer the lifestyle coaching in its entirety, and this option will be omitted for the patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Franciscus Gasthuis en Vlietland
Rotterdam, South Holland, 3045PM, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Taco Klem, MD,PHD
Franciscus Gasthuis & Vlietland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2022
First Posted
October 11, 2023
Study Start
December 1, 2022
Primary Completion
December 1, 2023
Study Completion
January 1, 2024
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share